In a recent white biotechnology day, attend by some 200 people,
‘s Evonik noted that the sector will see above average growth for the industry. It’s a message that seems to be gaining momentum, but perhaps more so in rhetoric than in practice. Germany
Evonik argues that the use of renewable raw materials presents special opportunities and prospects for the chemical industry. “Industrial biotechnology provides new approaches to manufacturing novel products with useful properties, or to manufacturing, for example, polymer building blocks and active ingredients by entirely different means. Because it is highly energy- and resource-efficient, white biotechnology is often an alternative to conventional chemical processes.”
In the health, nutrition and cosmetic markets, there are constantly new growth opportunities for bio-based products, it adds, showing that white biotechnology has above-average growth prospects. Besides the economic growth opportunities through biotechnology, the event also centered around “renewable resources.”
Evonik opens its Science-to-Business Center Biotechnology in January 2007 at its Marl site in Germany, where a host of experts from various disciplines are conducting research in “white biotechnology” in close cooperation with the business units and service units and a large number of external cooperation partners.
By conceiving new biotechnological products and processes, the center seeks to future-proof the core business of Evonik’s Chemicals Business Area. Biotechnological processes, unlike chemical processes, are notable primarily for their low investment costs. This means, for example, that a single bacterium can be used to perform multi-stage production sequences. The bacteria serve as “microbial cell factories.”